FDA Investigator Jocelyn E Sparks

Jocelyn E Sparks has inspections in 3 countries as of 27 Oct 2023. Jocelyn E Sparks has collaborated with a combinined 2256 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
23
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100009232
Country:
Germany, United States of America
Co-Investigator(s):
A Williams, Albert Rodriguez, Alexandra B Pitkin, Alexandria L Capuano, Allen F Hall, Althea A Williams, Amir Alavi, Anderson, Angela Shepas, Ashar P Parikh, Ashley A Mutawakkil, Bichsa T Tran, Binh T Nguyen, Bryan A Galvez, Carla J Lundi, Carolyn E Barney, Carr Sharpe, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Celena Ngo, Charles L Larson, Chelsea N Sealey, Cheryl D Mccall, Christopher R Czajka, Daniel R Solis, Daniel W Cline, Dannie E Rowland, David Kalins, David Serrano, Deborah A Greco, Dejon N Harris, Diane Cvan Leeuwen, Donna Ltartaglino Besone, Dr. Mark J Seaton, PhD, Durell L Giles, F Alex Slizza, Finn A Slizza, Francis J Eng, Gene D Arcy, Harperd, Herminio C Francisco, Jacqueline S Warner, James P Stallings, James P Stumpff, James R Fleckenstein, James W Leonette, Jane S Wernberg, Janet Pulver, Jennifer M Gogley, Jinnie Kokiatkulkij, Jocelyn E Massey, Joey V Quitania, John A Gonzalez, Juanita Banuelos, Ka L Wong, Kari M Johansen, Katherine E Jacobitz, Kelvin Cheung, Kevin N Tran, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kirtida Patel, Langer, Lanita F Kelley, Leonard H Lavi, Linda Thai, Lisa Shin, Louis B Cencetti, Louise B Cencetti, Mageet, Marcus F Yambot, Marie Falcone, Marie T Falcone, Mariza M Jafary, Mark A Tucker, Mark C Saale, Matthew J Johnson, Michael D Garcia, Michael O Stokke, Michael S Araneta, Michelle J Hines, Mihaly S Ligmond, Minh D Phan, Nancy L Neiger, Nicholas L Hunt, Norman Wong, Omotunde O Osunsanmi, Paquita F Segarra, Raymond T Oji, Richard L Rutherford, Richard W Tubb, Robert C Coleman, Sarah A Hassas, Scott K Zika, Selene T Torres, Sergio Chavez (NMI), Shafiq S Ahadi, Shaquenta Y Perkins, Sonya L Karsik, Stephanie A Slater, MS, Stephen D Eich, Steven E Porter, Jr, Sudipan Karmakar, Sumit Sen, Sunitha K Rajaram, PhD, Taichun Qin, PhD, Tamala P Magee, Terrance L Thomas, Terri L Dodds, Thao T Kwan, Thao X Ta, Theresa Kirkham (NMI), Tony J Wu, Trudy Papson, Trudy R Papson, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vashti E Bocker, Vickie L Anderson, Vicky L Cruz, Victor H Loo, Victor Loo, Virgilio F Pacio, CSO, William D Bassett, Jr, William D Boden, William J Leonard, William S Vitale, Wr Bowman, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis

Jocelyn E Sparks's Documents

Publish Date Document Type Title
October, 2002 FDA 483 Analytical Industries Inc - Form 483, 2002-10-30
April, 2005 EIR Wavelight GmbH - EIR, 2005-04-06
October, 2002 FDA 483 Urocare Products Inc - Form 483, 2002-10-01
November, 2002 FDA 483 Covidien Formerly Puritan Bennett Corp - Form 483, 2002-11-25
April, 2000 EIR American Dent-all Inc - EIR, 2000-04-26
April, 2006 EIR Carl Zeiss Meditec AG - EIR, 2006-04-13
August, 2003 FDA 483 Aaren Scientific, Incorporated - Form 483, 2003-08-26
May, 2004 FDA 483 Evermed Corp - Form 483, 2004-05-26
June, 2001 FDA 483 Panatrex, Incorporated - Form 483, 2001-06-14
December, 2001 EIR Avail Medical Products Inc - EIR, 2001-12-17
October, 2002 FDA 483 Lucas Medical, Inc. - Form 483, 2002-10-21
June, 2001 FDA 483 Response Panatrex, Inc. - Form 483R, 2001-06-22
November, 2007 FDA 483 Abbott Vascular - Form 483, 2007-11-15
July, 2003 EIR Integra NeuroSciences - EIR, 2003-07-17
April, 2000 FDA 483 American Dent-all Inc - Form 483, 2000-04-26
December, 2004 FDA 483 International Medication Systems, Ltd. - Form 483, 2004-12-17
August, 2002 EIR Edwards Lifesciences, LLC - EIR, 2002-08-06
November, 2002 EIR Allergan Sales, LLC - EIR, 2013-07-26
June, 2001 EIR Panatrex, Inc. - EIR, 2001-06-14
August, 2002 FDA 483 Edwards Lifesciences, LLC - Form 483, 2002-08-06
September, 2003 FDA 483 American Medical Devices Inc - Form 483, 2003-09-18
April, 2002 EIR Allergan - EIR, 2002-04-05
June, 2004 EIR Abbott Vascular - EIR, 2004-06-21
November, 2002 FDA 483 Newport Medical Instruments Inc - Form 483, 2002-11-12
November, 2003 FDA 483 Sigdestad, Leonard (DVM) - Form 483, 2003-11-18
November, 2002 EIR Covidien Formerly Puritan Bennett Corp - EIR, 2007-06-14
March, 2002 FDA 483 General Medical Company - Form 483, 2002-03-14

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more